CompletedPhase 2NCT01335932
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Studying Acute lung injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fred Hutchinson Cancer Center
- Principal Investigator
- Michael Boeckh, MD, M.DFred Hutchinson Cancer Center
- Intervention
- IV Ganciclovir(drug)
- Enrollment
- 160 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2016
Study locations (14)
- University of Colorado / National Jewish Health / Swedish Medical Center, Denver, Colorado, United States
- Northwestern University, Chicago, Illinois, United States
- Baystate Critical Care Medicine / Tufts University School of Medicine, Springfield, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Wakeforest University, School of Medicine, Winston-Salem, North Carolina, United States
- The Cleveland Clinic Foundation, Cleveland, Ohio, United States
- Ohio State University Medical Center, Columbus, Ohio, United States
- The Oregon Clinic, Portland, Oregon, United States
- University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
- University of Vermont College of Medicine, Burlington, Vermont, United States
- University of Virginia, Charlottesville, Virginia, United States
- Harborview Medical Center, Seattle, Washington, United States
- University of Washington Medical Center / Harborview Medical Center, Seattle, Washington, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01335932 on ClinicalTrials.govOther trials for Acute lung injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06526598Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) TrialCapital Medical University
- RECRUITINGNANCT07380789Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in UkraineLviv National Medical University
- RECRUITINGPHASE2, PHASE3NCT07342205A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota TransplantationShanghai University of Traditional Chinese Medicine
- RECRUITINGPHASE3NCT07208591To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress SyndromeStaidson (Beijing) Biopharmaceuticals Co., Ltd
- RECRUITINGPHASE2NCT06513949Anti-CD14 Treatment With IC14 in Hospitalized ARDS PatientsImplicit Bioscience
- RECRUITINGPHASE2NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PPD Development, LP
- RECRUITINGPHASE1, PHASE2NCT07413978A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress SyndromeChangchun Tuohua Pharmaceutical Co., Ltd.
- RECRUITINGNANCT06772025A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung MachineBayer